Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1110
0.00 (0.00%)
Aug 27, 2026, 3:50 PM HKT

Tianda Pharmaceuticals Balance Sheet

Millions HKD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
Cash & Equivalents
39.3364.8185.69162.44340.28334
Short-Term Investments
-6.66.148.4321.733.31
Trading Asset Securities
5.79---3.1714.58
Cash & Short-Term Investments
45.1271.4191.83170.87365.17351.9
Cash Growth
-54.11%-22.24%-46.26%-53.21%3.77%47.88%
Accounts Receivable
79.0876.4877.42104.8138.75141.74
Other Receivables
-2.843.971.574.073.15
Receivables
79.0879.3281.39106.38142.82144.89
Inventory
57.9144.6940.2165.1548.1974.89
Prepaid Expenses
10.932.242.451.811.995.76
Total Current Assets
193.03197.66215.88344.21558.17577.45
Property, Plant & Equipment
382.6384.66386.09412.74400.51433.09
Long-Term Investments
---9.220.741.77
Goodwill
83.0579.8990.3995.2395.95106.21
Other Intangible Assets
71.7827.2227.211.311.7515.51
Long-Term Deferred Charges
-41.5233.3219.364.376.43
Other Long-Term Assets
17.7216.8712.1435.2226.9723.7
Total Assets
748.18747.83765.02917.291,0881,164

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
Accounts Payable
94.9393.9677.82117.9980.73110.11
Accrued Expenses
-34.9229.3764.3171.1963.99
Short-Term Debt
-11.13----
Current Portion of Long-Term Debt
123.371.2122.0796.4964.6757.26
Current Portion of Leases
4.654.352.195.685.634.6
Current Income Taxes Payable
0.430.430.753.743.724.24
Current Unearned Revenue
-9.128.4313.71111.7314.08
Other Current Liabilities
58.8613.2110.3611.3824.7617.37
Total Current Liabilities
282.18238.32251313.31362.43271.66
Long-Term Debt
15.6441.92-8.3661.9790.63
Long-Term Leases
1.764.073.183.078.777.94
Long-Term Unearned Revenue
0.680.78--0.090.19
Long-Term Deferred Tax Liabilities
6.746.375.180.610.964.65
Total Liabilities
306.99291.46259.36325.35434.23375.08

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
Common Stock
215215215215215215
Additional Paid-In Capital
-359.07359.07364.66364.66364.66
Retained Earnings
--32.9537.0598.42128.17186.77
Comprehensive Income & Other
226.44-84.48-105.29-86.02-80-9.68
Total Common Equity
441.44456.64505.84592.07627.83756.75
Minority Interest
-0.25-0.28-0.17-0.1326.4132.32
Shareholders' Equity
441.19456.36505.67591.94654.24789.08
Total Liabilities & Equity
748.18747.83765.02917.291,0881,164

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
Total Debt
145.34132.66127.45113.6141.05160.43
Net Cash (Debt)
-100.23-61.25-35.6157.28224.12191.47
Net Cash Growth
----74.44%17.06%107.15%
Net Cash Per Share
-0.05-0.03-0.020.030.100.09
Filing Date Shares Outstanding
2,1502,1502,1502,1502,1502,150
Total Common Shares Outstanding
2,1502,1502,1502,1502,1502,150
Working Capital
-89.15-40.67-35.1230.9195.75305.79
Book Value Per Share
0.210.210.240.280.290.35
Tangible Book Value
286.61349.54388.24495.53530.13635.03
Tangible Book Value Per Share
0.130.160.180.230.250.30
Buildings
-253.23242.08228.71229.42249.16
Machinery
-231.26214.64212.46179.2184.23
Construction In Progress
-27.7225.3440.3928.9823.69
Leasehold Improvements
-5.295.724.714.024.17